BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with life-threatening rare diseases and medical conditions. The company's commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Firdapse (amifampridine phosphate) for Lambert Eaton Myasthenic Syndrome; Kuvan (sapropterin dihydrochloride) for phenylketonuria; Naglazyme (galsulfase) for Mucopolysaccharidosis VI; and Vimizim (elosulfase alpha) for Mucopolysaccharidosis IV Type A.
  • TickerBMRN
  • ISINUS09061G1013
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for BMRN

ValuEngine Rating and Forecast Report for BMRN

ValuEngine Rating and Forecast Report for BMRN

ValuEngine Rating and Forecast Report for BMRN

Liana Moussatos ...
  • Shveta Dighe

EMA Approved Palynziq for the Treatment of Phenylketonuria (PKU)

ValuEngine Rating and Forecast Report for BMRN

ValuEngine Rating and Forecast Report for BMRN

ValuEngine Rating and Forecast Report for BMRN

ValuEngine Rating and Forecast Report for BMRN

ValuEngine Rating and Forecast Report for BMRN

ValuEngine Rating and Forecast Report for BMRN

ValuEngine Rating and Forecast Report for BMRN

ValuEngine Rating and Forecast Report for BMRN

ValuEngine Rating and Forecast Report for BMRN

ValuEngine Rating and Forecast Report for BMRN

MarketLine Department

Repligen Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's Repligen Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Repligen Corporation since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantag...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch